American Association for the Study of Liver Diseases (AASLD)

Gloved hands putting together a liver out of puzzle pieces
Biotech

CymaBay tees up new phase 3 study for resurrected liver drug

CymaBay is getting its liver disease drug back on track with positive data out of a phase 3 study it cut short last year.
Amirah Al Idrus Nov 16, 2020 8:04pm
Gloved hands putting together a liver out of puzzle pieces

Glympse Bio clears first-in-human study of injectable biosensors

Nov 16, 2020 10:49am
vaccine

AASLD: VBI details hep B candidate as it preps 2020 filing

Nov 12, 2019 9:01am
Gilead Sign

AASLD: Gilead wants to move the needle for fatty liver therapies

Nov 11, 2019 8:35am